Stock listing
HKEX:2637 Fujian Haixi Pharmaceuticals Co., Ltd. (海西新藥) 股價
Follow Fujian Haixi Pharmaceuticals Co., Ltd. into a list and get an email when it puts out news.
Share price · HKEX:2637
$142.40 HKD +1.30 (+0.9%)
Close on Nov 3, 2026
- Day range
- $140.00 – $144.10 HKDNov 3, 2026
- Volume
- 31,250 sharesNov 3, 2026
- Market cap
- $11.21B HKDAt the close on Nov 3, 2026 · price × 78.71M shares outstanding
- 52-week range
- $111.00 – $302.40 HKDLowest and highest trades, Nov 4, 2025 – Nov 3, 2026
- Traded on an average day
- $20.10M HKDMedian day 71,450 shares · last 3 months, Aug 3, 2026 – Nov 3, 2026
Daily closes
Last 3 months, Aug 3, 2026 – Nov 3, 2026 · HKEX:2637 · HKD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $142.40 | +1.30 | +0.9% | $143.50 | $144.10 | $140.00 | 31,250 | |
| $141.10 | +1.80 | +1.3% | $139.60 | $144.70 | $139.00 | 28,000 | |
| $139.30 | -1.70 | -1.2% | $140.00 | $142.00 | $138.50 | 26,950 | |
| $141.00 | -2.30 | -1.6% | $143.30 | $143.30 | $138.00 | 41,250 | |
| $143.30 | +2.90 | +2.1% | $140.40 | $150.00 | $137.50 | 58,000 | |
| $140.40 | +0.90 | +0.6% | $140.00 | $141.00 | $138.00 | 29,000 | |
| $139.50 | -2.40 | -1.7% | $141.90 | $142.20 | $138.00 | 20,100 | |
| $141.90 | -0.30 | -0.2% | $140.70 | $142.80 | $138.00 | 38,650 | |
| $142.20 | +0.70 | +0.5% | $140.80 | $143.00 | $139.00 | 51,050 | |
| $141.50 | -9.40 | -6.2% | $154.60 | $154.60 | $140.00 | 243,850 | |
| $150.90 | -10.90 | -6.7% | $159.50 | $161.80 | $149.00 | 354,550 | |
| $161.80 | -1.40 | -0.9% | $167.20 | $167.20 | $159.70 | 28,050 | |
| $163.20 | -1.90 | -1.2% | $166.80 | $168.80 | $160.80 | 58,850 | |
| $165.10 | +11.20 | +7.3% | $156.00 | $166.00 | $154.30 | 86,850 | |
| $153.90 | +2.50 | +1.7% | $151.70 | $155.90 | $149.40 | 53,500 | |
| $151.40 | -4.10 | -2.6% | $153.60 | $156.30 | $149.60 | 58,500 | |
| $155.50 | +0.50 | +0.3% | $158.00 | $158.00 | $149.60 | 69,000 | |
| $155.00 | +0.10 | +0.1% | $163.50 | $163.50 | $153.00 | 85,350 | |
| $154.90 | -12.50 | -7.5% | $166.70 | $166.70 | $143.60 | 10,400 | |
| $167.40 | -0.60 | -0.4% | $168.00 | $168.00 | $167.40 | 50 | |
| $168.00 | +5.00 | +3.1% | $168.00 | $168.00 | $168.00 | 50 | |
| $163.00 | -3.00 | -1.8% | $166.00 | $166.00 | $163.00 | 200 | |
| $166.00 | -1.00 | -0.6% | $167.10 | $173.70 | $166.00 | 86,400 | |
| $167.00 | +1.50 | +0.9% | $166.00 | $169.20 | $166.00 | 42,000 | |
| $165.50 | -6.50 | -3.8% | $170.00 | $175.60 | $163.90 | 98,650 | |
| $172.00 | 0.00 | 0.0% | $172.00 | $172.00 | $172.00 | 150 | |
| $172.00 | -3.60 | -2.1% | $175.60 | $178.90 | $169.80 | 54,950 | |
| $175.60 | +0.30 | +0.2% | $178.00 | $179.90 | $175.50 | 39,950 | |
| $175.30 | -8.90 | -4.8% | $188.90 | $188.90 | $172.20 | 154,050 | |
| $184.20 | -8.50 | -4.4% | $192.70 | $194.70 | $183.90 | 43,050 | |
| $192.70 | +2.70 | +1.4% | $190.00 | $192.90 | $186.10 | 100,800 | |
| $190.00 | -8.40 | -4.2% | $200.00 | $202.00 | $181.50 | 493,900 | |
| $198.40 | +6.40 | +3.3% | $196.00 | $201.80 | $192.10 | 85,268 | |
| $192.00 | +2.00 | +1.1% | $194.90 | $196.30 | $189.30 | 47,000 | |
| $190.00 | -3.00 | -1.6% | $190.10 | $194.00 | $188.00 | 111,050 | |
| $193.00 | +3.30 | +1.7% | $185.40 | $198.80 | $183.20 | 147,650 | |
| $189.70 | -2.60 | -1.4% | $195.30 | $196.00 | $187.80 | 41,750 | |
| $192.30 | -4.40 | -2.2% | $195.10 | $201.40 | $191.40 | 128,250 | |
| $196.70 | -2.70 | -1.4% | $199.00 | $203.40 | $196.70 | 68,850 | |
| $199.40 | +0.10 | +0.1% | $199.00 | $200.80 | $196.60 | 36,050 | |
| $199.30 | -4.10 | -2.0% | $205.00 | $205.00 | $199.20 | 41,300 | |
| $203.40 | +5.10 | +2.6% | $202.00 | $204.60 | $198.10 | 112,050 | |
| $198.30 | +6.30 | +3.3% | $192.00 | $215.60 | $188.00 | 274,700 | |
| $192.00 | 0.00 | 0.0% | $192.10 | $194.00 | $186.00 | 105,050 | |
| $192.00 | -4.50 | -2.3% | $195.90 | $198.40 | $189.60 | 133,200 | |
| $196.50 | -2.10 | -1.1% | $207.00 | $207.00 | $196.50 | 27,250 | |
| $198.60 | +4.60 | +2.4% | $202.40 | $202.40 | $188.70 | 126,700 | |
| $194.00 | -6.00 | -3.0% | $203.20 | $206.80 | $194.00 | 82,050 | |
| $200.00 | +6.10 | +3.1% | $196.40 | $204.00 | $194.40 | 71,450 | |
| $193.90 | -7.10 | -3.5% | $198.00 | $203.20 | $192.50 | 70,300 | |
| $201.00 | -3.20 | -1.6% | $201.00 | $204.20 | $196.60 | 105,000 | |
| $204.20 | +4.20 | +2.1% | $208.00 | $211.20 | $196.40 | 225,850 | |
| $200.00 | -17.00 | -7.8% | $217.40 | $218.40 | $196.20 | 151,550 | |
| $217.00 | -4.20 | -1.9% | $230.00 | $248.00 | $213.00 | 341,750 | |
| $221.20 | +16.40 | +8.0% | $210.60 | $224.00 | $205.40 | 389,550 | |
| $204.80 | +6.50 | +3.3% | $197.30 | $211.80 | $197.30 | 327,350 | |
| $198.30 | +1.50 | +0.8% | $196.80 | $201.60 | $196.80 | 93,500 | |
| $196.80 | -4.00 | -2.0% | $202.80 | $202.80 | $192.60 | 52,650 | |
| $200.80 | -1.80 | -0.9% | $202.60 | $206.40 | $200.80 | 96,250 | |
| $202.60 | +5.90 | +3.0% | $192.50 | $205.80 | $192.50 | 215,750 | |
| $196.70 | -1.50 | -0.8% | $199.00 | $201.00 | $194.50 | 75,694 | |
| $198.20 | -1.60 | -0.8% | $199.70 | $205.60 | $196.90 | 41,550 | |
| $199.80 | +13.50 | +7.2% | $192.00 | $213.40 | $191.50 | 334,450 | |
| $186.30 | +9.00 | +5.1% | $186.40 | $186.40 | $178.50 | 177,600 | |
| $177.30 | +6.30 | +3.7% | $167.40 | $183.00 | $167.00 | 140,700 |
- Ticker
- HKEX:2637
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- HKEX
- Currency
- HKD
What changed lately
Latest news release · Nov 2, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Latest news
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Nov 2, 2026
Closed $142.40 (+0.9%) on Nov 3, 2026
Voluntary announcement - progress update on purchases of h shares pursuant to the share incentive scheme
Oct 20, 2026
Closed $141.50 (-6.2%) on Oct 21, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Oct 6, 2026
Closed $154.90 (-7.5%) on Oct 7, 2026
Interim report 2026
Sep 24, 2026
Closed $172.00 (0.0%) on Sep 25, 2026
Voluntary announcement - HX9428 latest data from Phase I and Phase II clinical studies for the treatment of neovascular age-related macular degeneration (nAMD)
Sep 16, 2026
Closed $190.00 (-4.2%) on Sep 17, 2026
Fujian Haixi Pharmaceuticals Says US FDA Approves IND Application Of HX9428
Aug 4, 2026
Closed $199.80 (+7.2%) on Aug 5, 2026
Fujian Haixi Pharmaceuticals Nominates Chen Tingze As Candidate For Executive Director
Jul 15, 2026
Closed $192.80 (-4.1%) on Jul 16, 2026
Fujian Haixi Pharmaceuticals Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 7 in the last 12 months · 7 in all · newest Nov 2, 2026 · oldest 2026
Log in to ask 6ix AI your own questions about Fujian Haixi Pharmaceuticals Co., Ltd.